1. Remote interactive evaluations of drug manufacturing and bioresearch monitoring facilities during the COVID-19 public health emergency Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, April 2021 Subject(s): Consumer Product SafetyDrug IndustryPharmaceutical ResearchCOVID-19United StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration